R&D

Suppressing the spread of tumors

Why some patients develop metastases and others do not is largely unclear. Researchers around ISTA professor Daria Siekhaus are now contributing to a better understanding of the process in certain types of cancer. They took a close look at the role of a protein called MFSD1 - the mammalian relative of a protein they had previously identified as affecting cell migration in fruit flies.

With personalized medicine, a shelved cancer drug could get another shot

A study by Virginia Commonwealth University Massey Cancer Center researchers published in today's print edition of Molecular Cancer Therapeutics shows that triplatin is effective against triple negative breast cancer, which is the most aggressive form of breast cancer and has few targeted therapies.

Three exposures to spike protein allow people to develop broad antibody immunity - also against Omicron

Scientists from Ludwig-Maximilians-Universitaet (LMU) in Munich, Helmholtz Munich, and Technical University of Munich have shown that the immune system is capable of neutralizing even Omicron after a total of three exposures to the viral spike protein.

Since the beginning of the COVID-19 pandemic, SARS-CoV-2 has continued to evolve, with new variants of concern (VoCs) spreading rapidly.

Compound in the herb rosemary may be useful against COVID-19 and other inflammatory diseases

A team co-led by scientists at Scripps Research has found evidence that a compound contained in the medicinal and culinary herb rosemary could be a two-pronged weapon against the SARS-CoV-2 coronavirus that causes COVID-19.

The scientists, in experiments described in a paper published January 6, 2022 in the journal Antioxidants, found that the compound, carnosic acid, can block the interaction between the SARS-CoV-2 outer "spike" protein and the receptor protein, ACE2, which the virus uses to gain entry to cells.

Study finds COVID-19 less severe in fully vaccinated

The clinical and imaging characteristics of COVID-19 breakthrough infections in fully vaccinated patients tend to be milder than those of partially vaccinated or unvaccinated patients, according to a new multicenter study published in the journal Radiology.

The number of confirmed COVID-19 cases worldwide now exceeds 270 million with an overall mortality rate of approximately 2%.

Current COVID-19 vaccines induce robust cellular immunity against Omicron variant

A highly mutated version of SARS-CoV-2, the virus that causes COVID-19, the Omicron variant has been shown to cause breakthrough infections among the vaccinated thanks to its ability to evade the virus-killing neutralizing antibodies that the body makes in response to getting vaccinated.

New study suggests two paths toward ‘super immunity’ to COVID-19

New laboratory research from Oregon Health & Science University reveals more than one path toward robust immunity from COVID-19.

A new study finds that two forms of immunity - breakthrough infections following vaccination or natural infection followed by vaccination - provide roughly equal levels of enhanced immune protection.

Research & Development

Suppressing the spread of tumors

With personalized medicine, a shelved cancer drug could get another shot

Three exposures to spike protein allow people to develop broad antibody immunity - also against Omicron

Compound in the herb rosemary may be useful against COVID-19 and other inflammatory diseases

Study finds COVID-19 less severe in fully vaccinated

Current COVID-19 vaccines induce robust cellular immunity against Omicron variant

New study suggests two paths toward ‘super immunity’ to COVID-19

More Pharma News ...